NDC 0008-2001-01 - Protonix I.V.
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0008-2001
- Requested NDC
- 0008-2001-01
- Package NDCs from labels
- 0008-2001-01, 0008-2001-25, 0008-2001-10
- Manufacturer
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC
- Effective date
- 2022-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC | 2022-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0008-2001-01 | EA - Each | 0008-2001 | ad389b07-7de3-422f-b0ff-7201c7e3a0c0 | 1 | 2014-04-03 |
| 0008-2001-10 | EA - Each | 0008-2001 | bda3bf5d-8674-4692-b11d-f8e080e04d1c | 1 | 2014-04-03 |
| 0008-2001-25 | EA - Each | 0008-2001 | 5d5925d0-ec2a-4b9a-aa1c-c0909dde694b | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM | ACTIVE INGREDIENT | 6871619Q5X | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| PANTOPRAZOLE | ACTIVE MOIETY | D8TST4O562 | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pantoprazole | PANTOPRAZOLE | PHOENIX RX LLC | 43fc6326-cfe6-7d1c-e063-6394a90abc24 | 2025-11-19 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Cardinal Health 107, LLC | 4ba4c797-3f97-4d85-971e-7b17bdf89221 | 2025-11-06 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | Advanced Rx of Tennessee, LLC | 4136d983-75fa-9604-e063-6294a90aaac6 | 2025-10-15 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Cardinal Health 107, LLC | 362229c5-7b28-4563-aa62-d97d06005480 | 2025-10-13 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM I.V. | PANTOPRAZOLE SODIUM | Piramal Critical Care | 0696b10c-972b-9dcf-e063-6294a90a1034 | 2025-10-07 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | PD-Rx Pharmaceuticals, Inc. | b422c5eb-9a6d-4f8c-863d-ca515ec780c2 | 2025-10-02 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE | Bryant Ranch Prepack | d212e8ec-f7ff-4727-a83e-0edc4ca7e6d1 | 2025-09-26 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole sodium delayed-release | PANTOPRAZOLE SODIUM DELAYED-RELEASE | Lifestar Pharma LLC | 0502f935-af7a-4f1e-8c3e-29e20647c885 | 2025-09-08 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM I.V. | PANTOPRAZOLE SODIUM | Sandoz Inc | 22b71a1d-87f8-43ba-b53d-53ca3f70c63e | 2025-07-30 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Devatis Inc. | 13c337e7-1e7b-47bd-9f88-92b0d548ca9c | 2025-07-30 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Mylan Institutional Inc. | a9b0d279-118b-4372-bd51-d4bad9c1cfca | 2025-07-22 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Meitheal Pharmaceuticals Inc. | 014f9762-6948-46b7-8659-5c89f35ad8bf | 2025-06-27 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Aphena Pharma Solutions - Tennessee, LLC | c9bc288b-e84c-4e31-a769-c87a59226086 | 2025-06-09 | Warnings, Adverse reactions | 6871619Q5X |
| Protonix I.V. | PANTOPRAZOLE SODIUM | Cardinal Health 107, LLC | 3cde88e6-28f2-4cbe-8c3f-770b05cc0e1b | 2025-04-22 | Warnings, Adverse reactions | NDA020988 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM INJECTION | Alembic Pharmaceuticals Limited | 02ee7ed6-217f-4128-bbbb-b9390475a65b | 2025-04-07 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM INJECTION | Alembic Pharmaceuticals Inc. | a9e5fac6-2db6-4311-a98b-eb3f0dde19d6 | 2025-04-07 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Rising Pharma Holdings, Inc. | 91a6b13f-457f-4136-9541-c4adb9c3c35c | 2025-04-02 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Aurobindo Pharma Limited | b3cec41e-e98b-470a-8ba2-c31537023989 | 2025-04-02 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release | PANTOPRAZOLE SODIUM GRANULES | Cipla USA Inc. | 195e06db-b76c-4470-b6a5-a3979c25046d | 2025-04-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole sodium | PANTOPRAZOLE SODIUM | Sun Pharmaceutical Industries Limited | eb3f58d4-0c69-4377-be45-c36099c98d33 | 2025-04-01 | Warnings, Adverse reactions | 6871619Q5X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.